Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1959 3
1960 1
1961 2
1967 1
1969 2
1971 1
1973 1
1975 1
1977 2
1982 2
1984 2
1985 1
1986 2
1987 1
1988 2
1989 2
1990 3
1991 4
1992 3
1993 3
1994 1
1995 2
1996 1
1997 3
1998 1
1999 1
2003 1
2004 2
2005 3
2006 6
2007 2
2008 6
2009 5
2010 6
2011 5
2012 8
2013 12
2014 14
2015 17
2016 6
2017 13
2018 10
2019 16
2020 16
2021 14
2022 22
2023 25
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators. Pfeffer MA, et al. N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225. N Engl J Med. 2015. PMID: 26630143 Free article. Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Irish Roma: a literature review.
O'Sullivan A, Rooney D, O'Gorman CS, Murphy AM. O'Sullivan A, et al. Among authors: rooney d. Ir J Med Sci. 2023 Apr;192(2):713-720. doi: 10.1007/s11845-022-03054-2. Epub 2022 Jun 18. Ir J Med Sci. 2023. PMID: 35717428 Free PMC article. Review.
Strategies to achieve a carbon neutral society: a review.
Chen L, Msigwa G, Yang M, Osman AI, Fawzy S, Rooney DW, Yap PS. Chen L, et al. Among authors: rooney dw. Environ Chem Lett. 2022;20(4):2277-2310. doi: 10.1007/s10311-022-01435-8. Epub 2022 Apr 8. Environ Chem Lett. 2022. PMID: 35431715 Free PMC article. Review.
Thermophysical properties of ionic liquids.
Rooney D, Jacquemin J, Gardas R. Rooney D, et al. Top Curr Chem. 2010;290:185-212. doi: 10.1007/128_2008_32. Top Curr Chem. 2010. PMID: 21107798 Review.
Artificial intelligence for waste management in smart cities: a review.
Fang B, Yu J, Chen Z, Osman AI, Farghali M, Ihara I, Hamza EH, Rooney DW, Yap PS. Fang B, et al. Among authors: rooney dw. Environ Chem Lett. 2023 May 9:1-31. doi: 10.1007/s10311-023-01604-3. Online ahead of print. Environ Chem Lett. 2023. PMID: 37362015 Free PMC article. Review.
234 results